114 related articles for article (PubMed ID: 8454649)
1. Effects of mutations that alter the Glu264-Lys387 salt bridge on the secretion of alpha-1-proteinase inhibitor.
Brodbeck RM; Samandari T; Brown JL
J Biol Chem; 1993 Mar; 268(9):6771-6. PubMed ID: 8454649
[TBL] [Abstract][Full Text] [Related]
2. A study of the effects of altering the sites for N-glycosylation in alpha-1-proteinase inhibitor variants M and S.
Samandari T; Brown JL
Protein Sci; 1993 Sep; 2(9):1400-10. PubMed ID: 8401226
[TBL] [Abstract][Full Text] [Related]
3. Construction and expression of alpha 1-proteinase inhibitor mutants and the effects of these mutations on secretion of the variant inhibitors.
McCracken AA; Kruse KB; Valentine J; Roberts C; Yohannes TZ; Brown JL
J Biol Chem; 1991 Apr; 266(12):7578-82. PubMed ID: 2019587
[TBL] [Abstract][Full Text] [Related]
4. Molecular basis for defective secretion of the Z variant of human alpha-1-proteinase inhibitor: secretion of variants having altered potential for salt bridge formation between amino acids 290 and 342.
McCracken AA; Kruse KB; Brown JL
Mol Cell Biol; 1989 Apr; 9(4):1406-14. PubMed ID: 2786139
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion.
Curiel DT; Chytil A; Courtney M; Crystal RG
J Biol Chem; 1989 Jun; 264(18):10477-86. PubMed ID: 2567291
[TBL] [Abstract][Full Text] [Related]
6. Study of the roles of proline 391 and a highly conserved sequence in the carboxyl-terminal region of members of the serpin family in the secretion of alpha 1-proteinase inhibitor.
Brodbeck RM; Brown JL
J Biol Chem; 1994 Jun; 269(25):17252-6. PubMed ID: 8006033
[TBL] [Abstract][Full Text] [Related]
7. Disruption of the Lys-290--Glu-342 salt bridge in human alpha 1-antitrypsin does not prevent its synthesis and secretion.
Foreman RC
FEBS Lett; 1987 May; 216(1):79-82. PubMed ID: 2884131
[TBL] [Abstract][Full Text] [Related]
8. Secretion of alpha-1-proteinase inhibitor requires an almost full length molecule.
Brodbeck RM; Brown JL
J Biol Chem; 1992 Jan; 267(1):294-7. PubMed ID: 1730596
[TBL] [Abstract][Full Text] [Related]
9. Disruption of the 290-342 salt bridge is not responsible for the secretory defect of the PiZ alpha 1-antitrypsin variant.
Sifers RN; Hardick CP; Woo SL
J Biol Chem; 1989 Feb; 264(5):2997-3001. PubMed ID: 2563374
[TBL] [Abstract][Full Text] [Related]
10. Alpha 1-proteinase inhibitor variant T345R. Influence of P14 residue on substrate and inhibitory pathways.
Hood DB; Huntington JA; Gettins PG
Biochemistry; 1994 Jul; 33(28):8538-47. PubMed ID: 8031789
[TBL] [Abstract][Full Text] [Related]
11. Selective protein degradation in the yeast exocytic pathway.
McCracken AA; Kruse KB
Mol Biol Cell; 1993 Jul; 4(7):729-36. PubMed ID: 8400458
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the properties of rare variants of alpha1-proteinase inhibitor expressed in COS-1 cells and assessment of their potential as risk factors in human disease.
Ray S; Mickleborough TD; Brown JL
Biochim Biophys Acta; 2005 Jun; 1740(3):390-402. PubMed ID: 15949707
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory activity and conformational transition of alpha 1-proteinase inhibitor variants.
Schulze AJ; Huber R; Degryse E; Speck D; Bischoff R
Eur J Biochem; 1991 Dec; 202(3):1147-55. PubMed ID: 1765073
[TBL] [Abstract][Full Text] [Related]
14. Ethanol dependence of alpha 1-antitrypsin C-terminal Lys truncation mediated by basic carboxypeptidases.
Matthiessen HP; Willemse J; Weber A; Turecek PL; Deiteren K; Hendriks D; Ehrlich HJ; Schwarz HP
Transfusion; 2008 Feb; 48(2):314-20. PubMed ID: 18028276
[TBL] [Abstract][Full Text] [Related]
15. Effect of modification of all loop regions in the alpha- and beta-subunits of human choriogonadotropin on its signal transduction activity.
Shao K; Purohit S; Bahl OP
Mol Cell Endocrinol; 1996 Sep; 122(2):173-82. PubMed ID: 8902847
[TBL] [Abstract][Full Text] [Related]
16. The effect of amino acid substitutions at position 342 on the secretion of human alpha 1-antitrypsin from Xenopus oocytes.
Wu Y; Foreman RC
FEBS Lett; 1990 Jul; 268(1):21-3. PubMed ID: 2384157
[TBL] [Abstract][Full Text] [Related]
17. Influence of the P5 residue on alpha1-proteinase inhibitor mechanism.
Chaillan-Huntington CE; Patston PA
J Biol Chem; 1998 Feb; 273(8):4569-73. PubMed ID: 9468513
[TBL] [Abstract][Full Text] [Related]
18. Intracellular retention and degradation of human mutant variant of a alpha 1-antitrypsin in stably transfected Chinese hamster ovary cell lines.
Ciccarelli E; Alonso MA; Cresteil D; Bollen A; Jacobs P; Alvarez F
Eur J Biochem; 1993 Apr; 213(1):271-6. PubMed ID: 8477700
[TBL] [Abstract][Full Text] [Related]
19. Intracellular processing of complement pro-C3 and proalbumin is inhibited by rat alpha 1-protease inhibitor variant (Met352----Arg) in transfected cells.
Misumi Y; Ohkubo K; Sohda M; Takami N; Oda K; Ikehara Y
Biochem Biophys Res Commun; 1990 Aug; 171(1):236-42. PubMed ID: 2393391
[TBL] [Abstract][Full Text] [Related]
20. Mutational, kinetic, and NMR studies of the mechanism of E. coli GDP-mannose mannosyl hydrolase, an unusual Nudix enzyme.
Legler PM; Massiah MA; Mildvan AS
Biochemistry; 2002 Sep; 41(35):10834-48. PubMed ID: 12196023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
